<DOC>
	<DOCNO>NCT00757601</DOCNO>
	<brief_summary>This study ass safety , tolerability , pharmacokinetics , pharmacodynamics single dos MK1006</brief_summary>
	<brief_title>A Study Test Safety , Tolerability , Pharmacokinetics , Pharmacodynamics MK1006 ( MK-1006-002 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Participant 18 55 year age . Participants 65 year age may enrol Panels B C Female participant must postmenopausal otherwise unable child Participant body mass index ( BMI ) less equal 42 kg/m^2 screen visit Participant type 2 diabetes treat either diet exercise single oral antihyperglycemic medication . For Panels B C , participant may treat combination oral antihyperglycemic medication Participant willing follow American Heart Association ( AHA ) diet exercise program throughout study Participant nonsmoker use nicotinecontaining product 6 month prior study start Participant history stroke , seizure , neurological disorder Participant recent history eye infection inflammatory eye condition Participant glaucoma blind Participant eye surgery within 6 month study start ( Lasik permit ) Participant type 1 diabetes Participant stop take current prescription nonprescription medication study Participant consume 3 alcoholic beverage per day Participant consume 6 caffeinated beverage per day Participant major surgery donate blood within 4 week study start Participant multiple and/or severe allergy drug food</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>